2025 Latin America Age-Related Mascular Degeneration Revenue Opportunities Report
Description
The 2025 Latin America Age-Related Mascular Degeneration Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Age-related Mascular Degeneration by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively involved in the Age-related Macular Degeneration (AMD) market in Latin America are Roche Holding AG, Novartis AG, Bayer AG, and SteinCares. Roche leads with its product Eylea, capturing over 53% of the market revenue share in 2021, mainly targeting wet AMD. Novartis promotes Lucentis, and Bayer markets Beovu, both significant therapies in the region's AMD treatment landscape. SteinCares has a strong biosimilar presence, partnering with Lupin to commercialize biosimilar ranibizumab across Latin America, expanding affordable treatment options and healthcare access in the region.
Additionally, LumiThera collaborates with Andrec Corporation to distribute its Valeda Light Delivery System for dry AMD, addressing a largely underserved dry AMD segment in Latin America. Andrec's widespread network covers countries including Colombia, Peru, Ecuador, Venezuela, Chile, and others, enhancing treatment availability via innovative photobiomodulation therapy. These companies together represent the forefront of pharmaceutical and device innovation actively pursuing AMD treatment advancements in Latin America, tackling both wet and dry forms of the disease.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Age-related Mascular Degeneration by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively involved in the Age-related Macular Degeneration (AMD) market in Latin America are Roche Holding AG, Novartis AG, Bayer AG, and SteinCares. Roche leads with its product Eylea, capturing over 53% of the market revenue share in 2021, mainly targeting wet AMD. Novartis promotes Lucentis, and Bayer markets Beovu, both significant therapies in the region's AMD treatment landscape. SteinCares has a strong biosimilar presence, partnering with Lupin to commercialize biosimilar ranibizumab across Latin America, expanding affordable treatment options and healthcare access in the region.
Additionally, LumiThera collaborates with Andrec Corporation to distribute its Valeda Light Delivery System for dry AMD, addressing a largely underserved dry AMD segment in Latin America. Andrec's widespread network covers countries including Colombia, Peru, Ecuador, Venezuela, Chile, and others, enhancing treatment availability via innovative photobiomodulation therapy. These companies together represent the forefront of pharmaceutical and device innovation actively pursuing AMD treatment advancements in Latin America, tackling both wet and dry forms of the disease.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
